To the full analysis
Vicore Pharma Holding stock: growth
VICO.STVicore Pharma Holding reported $382.74K in revenue for fiscal 2025, down 96.5% on the prior year.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
72%
per year from 2012 to 2025, per share −13%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | no data | 16.3% | 72.0% |
| Revenue per share | no data | −12.4% | −13.0% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $332.3 | −$316.66 | −$170.46 |
| 2013 | $331.4K | −$160.74K | −$179.79K |
| 2014 | $157.53K | $1.37M | −$1.23M |
| 2015 | $84.23K | −$458.24K | −$936.44K |
| 2016 | $85.43K | −$667.01K | −$2.08M |
| 2017 | $93.45K | −$1.29M | −$2.8M |
| 2018 | $50.94K | −$2.17M | −$3.51M |
| 2019 | $0 | −$9.33M | −$8.74M |
| 2020 | $0 | −$14.73M | −$12.33M |
| 2021 | $0 | −$29.73M | −$26.59M |
| 2022 | $0 | −$28.92M | −$30.37M |
| 2023 | $0 | −$31.18M | −$44.98M |
| 2024 | $10.96M | −$16.91M | −$16.54M |
| 2025 | $382.74K | −$47.88M | −$37.68M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Dec 2016)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.